Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cipla
Farmers Insurance
Medtronic
Fish and Richardson
Moodys

Generated: August 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PULMICORT FLEXHALER

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Clinical Trials for Pulmicort Flexhaler

Trial ID Title Status Sponsor Phase Summary
NCT00702325 Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans Completed AstraZeneca Phase 4 To compare the efficacy of SYMBICORT® pMDI 160/4.5 μg x 2 actuations twice daily (bid) to that of budesonide inhalation powder DPI 180 μg x 2 inhalations bid, in African American(self-reported) subjects with inhaled corticosteroid (ICS) dependent asthma.
NCT01218399 Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations Completed AstraZeneca N/A This is an investigator-initiated study in which Dr. Nadeau wrote the protocol and received funding from an Astra Zeneca grant to direct, perform, and monitor the study on her own with Stanford staff. We hypothesize that the budesonide/formoterol combination improves the efficacy of budesonide alone.
NCT01218399 Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations Completed Stanford University N/A This is an investigator-initiated study in which Dr. Nadeau wrote the protocol and received funding from an Astra Zeneca grant to direct, perform, and monitor the study on her own with Stanford staff. We hypothesize that the budesonide/formoterol combination improves the efficacy of budesonide alone.
Trial ID Title Status Sponsor Phase Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Pulmicort Flexhaler

Condition Name

Condition Name for Pulmicort Flexhaler
Intervention Trials
Asthma 4
Relative Bioavailability 1
Osteoporosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pulmicort Flexhaler
Intervention Trials
Asthma 3
Osteoporosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pulmicort Flexhaler

Trials by Country

Trials by Country for Pulmicort Flexhaler
Location Trials
United States 27
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pulmicort Flexhaler
Location Trials
Florida 2
Pennsylvania 2
New York 2
Maryland 2
California 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pulmicort Flexhaler

Clinical Trial Phase

Clinical Trial Phase for Pulmicort Flexhaler
Clinical Trial Phase Trials
Phase 4 3
Phase 1 1
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pulmicort Flexhaler
Clinical Trial Phase Trials
Completed 4
Withdrawn 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pulmicort Flexhaler

Sponsor Name

Sponsor Name for Pulmicort Flexhaler
Sponsor Trials
AstraZeneca 4
Stanford University 1
Columbia University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pulmicort Flexhaler
Sponsor Trials
Industry 4
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Covington
Teva
US Army
Harvard Business School
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.